SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. - Wikidata - awgldk - TriplyDB

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

http://www.wikidata.org/entity/Q41882825

about

Adipocyte extracellular matrix composition, dynamics and role in obesity SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane Laminin α4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain Loss of SPARC in bladder cancer enhances carcinogenesis and progression.Thrombospondin-2 is an endogenous adipocyte inhibitor.Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork A role for SPARC in the moderation of human insulin secretion Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus.Secreted protein acidic and rich in cysteine internalization and its age-related alterations in skeletal muscle progenitor cells.Anti-cancer role of SPARC, an inhibitor of adipogenesis Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles.Revisiting the matricellular concept.Matricellular proteins in cardiac adaptation and disease.The delayed recovery of the remobilized rat tibialis anterior muscle reflects a defect in proliferative and terminal differentiation that impairs early regenerative processes ECM roles in the function of metabolic tissues.Adipose progenitor cells reside among the mature adipocytes: morphological research using an organotypic culture system.Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats Age-related resistance of skeletal muscle-derived progenitor cells to SPARC may explain a shift from myogenesis to adipogenesis.Association of serum SPARC level with severity of coronary artery lesion in type 2 diabetic patients with coronary heart disease Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose The role of SPARC in extracellular matrix assembly.SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue.The regulatory function of SPARC in vascular biology.New insights into adipose tissue dysfunction in insulin resistance.Role of SPARC in bone remodeling and cancer-related bone metastasis.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin Proteolytic Isoforms of SPARC Induce Adipose Stromal Cell Mobilization in Obesity.Pleiotropic roles of the matricellular protein Sparc in tendon maturation and ageing.Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.The role of thrombospondin (TSP)-1 in obesity and diabetes.Matricellular proteins: an overview.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.SPARC functions as an inhibitor of adipogenesis.The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling.RNA-seq analysis of bovine intramuscular, subcutaneous and perirenal adipose tissues.Inactivation of SPARC enhances high-fat diet-induced obesity in mice.

P2860

Q24627461-11B90430-1EDD-48B6-8C44-BD20758D700C Q27309073-7970B062-B12D-4D4B-8A4C-8D431C3C1CB9 Q27336438-35DAC5E7-21AA-48E2-8526-072601022B2B Q30422650-0D22A147-FB18-4E72-9E33-D5F719233A5F Q34127148-5D12D287-870F-40AE-9D70-CE0B15CD653A Q34547034-7DB4B276-1E12-4FCA-961F-215DA6E2D2FA Q34808686-47EBE88C-27FA-47D2-902C-95C2B9583A13 Q35069694-97DD5DE9-CC6A-4290-870F-AF6321AE85C9 Q35080462-92B0B56F-C3E1-456F-9EC4-A3073D32AA43 Q35116107-6C3B5E42-4987-4F43-B814-33BF4479FB89 Q35122148-28F95B48-968A-43E9-AB0D-9A3F1A97C87E Q35233858-FB4E45F7-7A9B-4D25-9BA0-20472F6BF4E2 Q35542423-3908E9C1-2DB9-4E4C-87F6-14C9DAA5D112 Q35617688-5B8CB7E7-7FA1-41F8-B30B-75ED97D5D479 Q35653088-2CD76245-81E2-4681-8C56-75D85AEEA563 Q35669821-BC30DF12-8F1F-4D76-837B-F963A673AF7A Q35674489-45171D24-15A5-4D18-B4FB-ADE48A2CD0B1 Q35799820-BA8C99B6-CD0C-452B-AFFC-E3417D1A266B Q36412223-564E768A-EAC0-4344-857D-56E6AA3BF86A Q37093613-B722FD7D-25C7-488E-931C-71BDAD4202E1 Q37245971-97C99282-B9D8-46B6-AF28-2B84E7AA5634 Q37267107-4399ADEB-6360-44F7-A7DF-14BEF0C05C59 Q37607131-F7899AB4-AB7B-4AAD-9C8C-54904F8672F9 Q37679943-FA40B481-6E45-442A-B760-DCE8EE30A90C Q37848921-795CCE85-BBD3-431A-902F-6F95268AA5D6 Q37913130-A9901B5A-C617-4F54-A442-E42659099869 Q37926599-47EA9A40-42DC-4576-B44E-4380CFDA76AB Q38137862-77A6426F-7B2B-4DC2-8559-418CFF14C2BB Q38199932-5C43B849-E042-4CCD-A23B-B5EE4B6F94EF Q39431361-15003091-75E0-4116-A87D-10EF4A673C5D Q40527980-7A1D6F9A-B07C-4592-809C-B1EFA658C13F Q41002949-079463D3-1D9A-41E3-8C56-5D12BE03B3DE Q41183233-8F7B3825-7ED1-4AC3-96FE-83CB6369C408 Q41933144-BEE978F1-660F-4EE2-AC97-DB240D597D3B Q42096914-26A8C07B-9708-42D8-A75A-6832629A0907 Q42362739-02FBE24A-FF4E-44BB-BFDC-97F7919FFBC2 Q42643959-ACC47585-E99B-4ACC-962B-73A8250DDEF7 Q42709950-FB78376C-6439-43BD-84F3-1264106F45D6 Q42774497-C5828E48-48A7-446A-AE36-8861AA383403 Q44957927-89D493FB-E238-4E67-BBBA-17C0BBB40C3F

P2860

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

http://www.wikidata.org/entity/Q41882825

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

@en

type

label

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

@en

prefLabel

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

@en

P1433

Q41882825-2FEF3882-BAB3-4266-A14C-53CF816DF669

P1476

Q41882825-3F650C5E-DA56-4889-9758-41EEF1379B0D

P2093

Q41882825-A6E23F88-80C7-440D-BD9C-8566B4359FE1

Q41882825-E392D303-3310-46F0-B9D3-7F27BB528E27

P2860

Q41882825-003A59D8-7ABD-467F-8D71-A3622CC6C1C2

Q41882825-09EC787F-7BAA-4CDE-BB05-BD3B07D57FB2

Q41882825-0CFB739A-FD38-47B8-8847-014FEC0403AD

Q41882825-0E463C20-0AC6-4011-BBAA-782E95576235

Q41882825-22A96659-F665-4AD0-B793-4AD9C40282A8

Q41882825-25A54B62-119A-4391-8C70-AA65634D7546

Q41882825-280871E1-4F45-4DB7-92D7-63C80BB954B2

Q41882825-291FB618-9E7B-4D85-AE82-47FE28CA5D26

Q41882825-3709B900-750F-41FF-94F7-94BBB01C48AF

Q41882825-4064E720-CA31-4BD7-814F-526D852A7C8D

P304

Q41882825-79D140BF-E856-4CCC-9A5E-417C1FA185B3

P31

Q41882825-52F239A5-A864-4C95-9C3F-D9009FEEE33C

P356

Q41882825-AE3F6520-F25E-4CA3-B0D1-4E777A6FFA97

P407

Q41882825-82758CF7-357D-48A5-9D2A-547FDA234A95

P433

Q41882825-E8207901-754D-4161-BEA8-1CD3EB8BBDCB

P478

Q41882825-01ACFFEC-107A-454A-B700-FB4A233344CE

P577

Q41882825-001B0A1C-9E9F-490F-9C21-1A89444E5C63

P698

Q41882825-9C004FBC-35C0-43BF-8849-539B3CC06A42

P932

Q41882825-BD6DE064-D728-4D62-9C3B-F14152702A62

P356

P1433

Journal of Biological Chemistry

P1476

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

@en

P2093

E Helene Sage

http://www.w3.org/2001/XMLSchema#string

Jing Nie

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of adipogenesis by Wnt signaling

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase

Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells

Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

APC-dependent suppression of colon carcinogenesis by PPARgamma

Mitotic clonal expansion: a synchronous process required for adipogenesis

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.

P304

1279-1290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M808285200

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18990699

http://www.w3.org/2001/XMLSchema#string

P932

2613608

http://www.w3.org/2001/XMLSchema#string